Gallith
To improve the condition of minor bilious problems.
Anti-inflammatory, spasmolytic and choleretic.
Well proven for more than 50 years.
Well documented traditional medicinal plant.
Over-the-counter medicine.
Local Pharmacies
Advantages of Gallith1
- Effective and safe in treating gallbladder complaints.
- Continuous improvement possible of chronic gallbladder complaints with excellent tolerability in long-term use. 1,2
- Anti-inflammatory plant extract. simultaneously gallstone dissolving.
- Listed in the important pharmacopoeias and monographs.
The extract of Glechoma hederacea consists of a large number of pharmacologically active components with multiple effects that form the basis for the treatment of biliary discomfort.
Choleretic
Liver-protective
Anti-inflammatory
Reducing the inflammatory process in the gallbladder wall.
The inflammatory reaction can be caused by mechanical irritation attributable to gallstones and may be accompanied by complaints. 3
Spasmolytic
Antimicrobial 3
Mandatory Information
Gallith soft capsules
1 capsule contains:
Active ingredient: Purified extract of Glechoma hederacea (2:1), first extraction solvent ethanol 96% (V/V), 100 mg
Area of application:
Gallith is used in adults to improve the condition of mild gallbladder complaints such as bloating and flatulence caused by known gallstones not requiring surgery.
Gallith is a traditional herbal medicinal product registered for its indication only based on longstanding use.
For risks and side effects, please ask your doctor and pharmacist.
References:
1 Hoffmann J, Aye RD (1978) Zur Auflösung und Rezidiv-Prophylaxe von Cholesterin-Gallensteinen mit Hedera-Extrakt, Erfahrungsheilkunde 227 (12) – Sonderdruck.
2 Fuchs-Algrim J, Lorenz H. 2003. Wirksamkeit und Verträglichkeit von Hitrechol bei der medikamentösen Auflösung von Cholesteringallensteinen sowie der Behandlung von Begleitbeschwerden. Integrierter finaler Report der Studie IBP 312001/93.
3 Casey HJ (1976) Efficacy study on gallstones remedy, vegetable extract II, Final Report of the Study Ref. No. 11/7606, Pharmazeutische Fabrik Evers & Co. GmbH